- Home
- EBS vs BRW Comparison
EBS vs BRW Comparison
Compare EBS & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- BRW
- Stock Information
- Founded
- EBS 1998
- BRW 1987
- Country
- EBS United States
- BRW United States
- Employees
- EBS N/A
- BRW N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- BRW Trusts Except Educational Religious and Charitable
- Sector
- EBS Health Care
- BRW Finance
- Exchange
- EBS Nasdaq
- BRW Nasdaq
- Market Cap
- EBS 359.3M
- BRW 355.1M
- IPO Year
- EBS 2006
- BRW N/A
- Fundamental
- Price
- EBS $8.15
- BRW $8.12
- Analyst Decision
- EBS Strong Buy
- BRW
- Analyst Count
- EBS 3
- BRW 0
- Target Price
- EBS $14.33
- BRW N/A
- AVG Volume (30 Days)
- EBS 1.0M
- BRW 222.1K
- Earning Date
- EBS 11-05-2025
- BRW 01-01-0001
- Dividend Yield
- EBS N/A
- BRW 15.59%
- EPS Growth
- EBS N/A
- BRW N/A
- EPS
- EBS 2.53
- BRW N/A
- Revenue
- EBS $851,600,000.00
- BRW N/A
- Revenue This Year
- EBS N/A
- BRW N/A
- Revenue Next Year
- EBS $19.24
- BRW N/A
- P/E Ratio
- EBS $3.22
- BRW N/A
- Revenue Growth
- EBS N/A
- BRW N/A
- 52 Week Low
- EBS $4.02
- BRW $7.15
- 52 Week High
- EBS $12.73
- BRW $8.30
- Technical
- Relative Strength Index (RSI)
- EBS 51.40
- BRW 37.32
- Support Level
- EBS $7.45
- BRW $8.06
- Resistance Level
- EBS $8.62
- BRW $8.28
- Average True Range (ATR)
- EBS 0.40
- BRW 0.09
- MACD
- EBS -0.10
- BRW -0.02
- Stochastic Oscillator
- EBS 38.46
- BRW 15.00
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About BRW Saba Capital Income & Opportunities Fund SBI
Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.